Search research articles
Contact Us
Filters
Showing results (221-230 of 248) with videos related to
Page
of 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 15, 2018
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial
Mahasweta Gooptu, Haesook T Kim, Yi-Bin Chen, et al.
Blood
|
August 17, 2012
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
Jessica L Allen, Matthew S Fore, Jenna Wooten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
Steven M Devine, Kouros Owzar, William Blum, et al.
Developmental Biology
|
March 26, 2003
ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets
Paul W Wright, Laura C Bolling, Meredith E Calvert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2002
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies
Robert Z Orlowski, Thomas E Stinchcombe, Beverly S Mitchell, et al.
Blood
|
August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
Koen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.
British Journal of Haematology
|
December 20, 2016
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106
Robert W Chen, Hongli Li, Steven H Bernstein, et al.
The Lancet. Haematology
|
March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 study
Natalie S Grover, George Hucks, Marcie L Riches, et al.
Leukemia & Lymphoma
|
January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Zeina Al-Mansour, Hongli Li, James R Cook, et al.
The New England Journal of Medicine
|
November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Patrick J Stiff, Joseph M Unger, James R Cook, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 248) with videos related to
Sort By:
Page
of 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 15, 2018
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial
Mahasweta Gooptu, Haesook T Kim, Yi-Bin Chen, et al.
Blood
|
August 17, 2012
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
Jessica L Allen, Matthew S Fore, Jenna Wooten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
Steven M Devine, Kouros Owzar, William Blum, et al.
Developmental Biology
|
March 26, 2003
ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets
Paul W Wright, Laura C Bolling, Meredith E Calvert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2002
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies
Robert Z Orlowski, Thomas E Stinchcombe, Beverly S Mitchell, et al.
Blood
|
August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
Koen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.
British Journal of Haematology
|
December 20, 2016
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106
Robert W Chen, Hongli Li, Steven H Bernstein, et al.
The Lancet. Haematology
|
March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 study
Natalie S Grover, George Hucks, Marcie L Riches, et al.
Leukemia & Lymphoma
|
January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Zeina Al-Mansour, Hongli Li, James R Cook, et al.
The New England Journal of Medicine
|
November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Patrick J Stiff, Joseph M Unger, James R Cook, et al.
Page
of 25